Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2020
Source ID
10.1016/j.cell.2020.04.020

Entities

People

  • Augustine Chemparathy
  • David B. Lewis
  • Drew Endy
  • Girija Dhamdhere
  • Laine Goudy
  • Lei S Qi
  • Leiping Zeng
  • Marie La Russa
  • Nicholas S Heaton
  • Robert Debs
  • Stephen Chmura
  • Tara Pande
  • Timothy R. Abbott
  • Xueqiu Lin
  • Yanxia Liu

Organizations

  • Defense Advanced Research Projects Agency
  • Li Ka Shing Foundation

Tags

Technology Areas

  • Biotechnology